Ocugen, Inc. — Investor Relations & Filings
Ocugen, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing novel gene therapies, cell therapies, and vaccines. The company's primary mission is to develop treatments for blindness diseases, leveraging its first-in-class modifier gene therapy platform. This platform represents a potential paradigm shift in treating inherited retinal diseases by aiming to address multiple genetic mutations with a single product. In addition to its focus on ocular health, Ocugen is also advancing a pipeline that includes vaccines for infectious diseases. The company is dedicated to addressing significant unmet medical needs and providing innovative therapeutic options for patients with debilitating conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-14 | English | |
| FORM 8-K | 2026-05-14 | English | |
| 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-05-05 | English | |
| 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-05-04 | English | |
| ARS - Ocugen, Inc. (0001372299) (Filer) | 2026-04-28 | English | |
| SCHEDULE 13G/A - Ocugen, Inc. (0001372299) (Subject) | 2026-03-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46257527 | FORM 8-K | 2026-05-14 | English | ||
| 46289439 | FORM 8-K | 2026-05-14 | English | ||
| 41428961 | 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-05-05 | English | ||
| 41043585 | 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-05-04 | English | ||
| 37961514 | ARS - Ocugen, Inc. (0001372299) (Filer) | 2026-04-28 | English | ||
| 33062206 | SCHEDULE 13G/A - Ocugen, Inc. (0001372299) (Subject) | 2026-03-27 | English | ||
| 33033584 | 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-03-24 | English | ||
| 32998803 | 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-03-20 | English | ||
| 32890785 | 10-K - OCUGEN, INC. (0001372299) (Filer) | 2026-03-04 | English | ||
| 32890779 | 8-K - OCUGEN, INC. (0001372299) (Filer) | 2026-03-04 | English | ||
| 32890780 | 8-K - OCUGEN, INC. (0001372299) (Filer) | 2026-03-04 | English | ||
| 29170586 | 8-K Filing | 2026-02-09 | English | ||
| 29170562 | SCHEDULE 13G Filing | 2026-01-30 | English | ||
| 29170569 | 8-K Filing | 2026-01-23 | English | ||
| 29170585 | 8-K Filing | 2026-01-21 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alembic Ltd
Vertically integrated producer of generic pharmaceuticals a…
|
ALEMBICLTD | IN | Manufacturing |
|
ALEMBIC PHARMACEUTICALS LIMITED
Vertically integrated developer of generic drugs, APIs, and…
|
APLLTD | IN | Manufacturing |
|
ALIVUS LIFE SCIENCES LIMITED
Produces and distributes diverse pharmaceuticals across mul…
|
ALIVUS | IN | Manufacturing |
|
ALK-Abelló
A pharmaceutical company specializing in allergy prevention…
|
ALK | DK | Manufacturing |
|
Alkaloid AD
Manufactures generic pharmaceuticals, cosmetics, and chemic…
|
ALK | MK | Manufacturing |
|
Alkem Laboratories Limited
Develops, manufactures, and markets pharmaceutical and nutr…
|
ALKEM | IN | Manufacturing |
|
Alkermes plc.
Develops and commercializes medicines for central nervous s…
|
ALKS | US | Manufacturing |
|
Allarity Therapeutics, Inc.
A clinical-stage biopharma using diagnostics to develop tar…
|
ALLR | US | Manufacturing |
|
ALLERGY THERAPEUTICS PLC
Immunology company developing aluminum-free vaccines and th…
|
AGY | GB | Manufacturing |
|
Alliance Growers Corp.
Diversified global medical cannabis company focused on CBD …
|
ALGWF | CA | Manufacturing |
Ocugen, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32915/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32915 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32915 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32915 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32915}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Ocugen, Inc. (id: 32915)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.